Bridgeway Capital Management, LLC Amylyx Pharmaceuticals, Inc. Transaction History

Bridgeway Capital Management, LLC

  • $4.38 Billion
  • Q3 2025

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 14, 2025
SELL
$3.31 - $6.5 $430,300 - $845,000
-130,000 Reduced 83.49%
25,700 $164,000
Q1 2025

May 15, 2025
BUY
$3.0 - $4.15 $27,600 - $38,180
9,200 Added 6.28%
155,700 $551,000
Q4 2024

Feb 14, 2025
BUY
$2.94 - $7.03 $48,510 - $115,995
16,500 Added 12.69%
146,500 $552,000
Q2 2024

Aug 14, 2024
BUY
$1.62 - $2.71 $210,600 - $352,300
130,000 New
130,000 $247,000

Others Institutions Holding AMLX

# of Institutions
183
Shares Held
94.1M
Call Options Held
421K
Put Options Held
174K
View Full List

About Amylyx Pharmaceuticals, Inc.

AMLX Quotes by TradingView
  • Ticker AMLX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 58,533,200
  • Market Cap $743M
  • Description
  • Amylyx Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, engages in developing various therapeutics for amyotrophic lateral sclerosis (ALS) and other neurodegenerative diseases. The company's product pipeline includes AMX0035, a dual UPR-Bax apoptosis inhibitor composed of sodium phenylbutyrate and taurursodiol for the treatment...
More about AMLX
Track This Portfolio

Track Bridgeway Capital Management, LLC Portfolio

Follow Bridgeway Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bridgeway Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bridgeway Capital Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email